Researchers at the National Institute of Standards and Technology (NIST) have developed a prototype bioreactor—a device for culturing cells to create engineered tissues—that both stimulates and evaluates tissue as it grows, mimicking natural processes while eliminating the need to stop periodically to cut up samples for analysis.

Dr.

BALTIMORE, March 15, 2012 /PRNewswire/ -- Approximately 140 million adults in the U.S.

Stanford University School of Medicine investigators have shown that iPS cells, viewed as a possible alternative to human embryonic stem cells, can mirror the defining defects of a genetic condition — in this instance, Marfan syndrome — as well as embryonic stem cells can.

BURLINGTON, Mass., March 31, 2011 /PRNewswire/ -- Keystone Dental, an oral healthcare company focused on enhancing every patient's smile, is excited to announce the launch of DynaMatrix(TM) Plus, a soft tissue regeneration product specifically designed to serve as an alternative to patient's own tissue for root coverage and tissue bulking procedures. "DynaMatrix Plus has been developed based on clinician feedback and the success of DynaMatrix(TM) Extracellular Membrane," said Patrick McGloin, SVP of Commercial Operations for Keystone Dental.